ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma

Currently the diagnosis of pancreatic ductal adenocarcinoma (PDAC) relies on CA19-9 and radiological means, whereas some patients do not have elevated levels of CA19-9 secondary to pancreatic cancer. The purpose of this study was to identify potential serum biomarkers for CA19-9 negative PDAC. A tot...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chao, Wu, Wen-Chuan, Zhao, Guo-Chao, Wang, Dan-Song, Lou, Wen-Hui, Jin, Da-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979862/
https://www.ncbi.nlm.nih.gov/pubmed/27495108
http://dx.doi.org/10.1097/MD.0000000000004527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979862/
https://www.ncbi.nlm.nih.gov/pubmed/27495108
http://dx.doi.org/10.1097/MD.0000000000004527

Ejemplares similares